Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nektar Therapeutics - Common Stock (NQ:NKTR)

31.52 +7.07 (+28.90%)
Streaming Delayed Price Updated: 10:37 AM EDT, Jun 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,050,054
Open 24.88
Bid (Size) 31.43 (1)
Ask (Size) 31.60 (11)
Prev. Close 24.45
Today's Range 23.33 - 34.83
52wk Range 0.4320 - 27.68
Shares Outstanding 183,801,441
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
+3179.4%
+3179.4%
1 Month
+4572.3%
+4572.3%
3 Month
+3663.9%
+3663.9%
6 Month
+3371.6%
+3371.6%
1 Year
+2593.6%
+2593.6%

More News

Read More
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further
Via Stocktwits
Topics Economy Government
Crude Oil Falls Sharply; US Current Account Deficit Widens In Q1
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Nektar Therapeutics's Earnings: A Preview
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Which stocks are gapping on Tuesday?
Via Chartmill
Nasdaq Surges 1%; TD Synnex Posts Upbeat Earnings
Via Benzinga
Nektar Therapeutics Shares Double On Promising Eczema Drug Data
Via Benzinga
Nektar Therapeutics Launches By Triple Digits On Eczema Grand Slam
Via Investor's Business Daily
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
US Stocks Likely To Open Higher After Trump Announces Iran-Israel Ceasefire: FedEx, TD Synnex In Focus Ahead Of Earnings
Via Benzinga
Topics Government
Nektar Therapeutics Stock Rallies Sharply After-Hours With Major Skin Drug Results Just Hours Away
Via Stocktwits
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers in Monday's after hours session
Via Chartmill
Assessing Nektar Therapeutics: Insights From 5 Financial Analysts
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Assessing Nektar Therapeutics: Insights From 4 Financial Analysts
Via Benzinga
Earnings Scheduled For March 12, 2025
Via Benzinga
Top movers in Friday's after hours session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga

Frequently Asked Questions

Is Nektar Therapeutics - Common Stock publicly traded?
Yes, Nektar Therapeutics - Common Stock is publicly traded.
What exchange does Nektar Therapeutics - Common Stock trade on?
Nektar Therapeutics - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nektar Therapeutics - Common Stock?
The ticker symbol for Nektar Therapeutics - Common Stock is NKTR on the Nasdaq Stock Market
What is the current price of Nektar Therapeutics - Common Stock?
The current price of Nektar Therapeutics - Common Stock is 31.52
When was Nektar Therapeutics - Common Stock last traded?
The last trade of Nektar Therapeutics - Common Stock was at 06/25/25 10:37 AM ET
What is the market capitalization of Nektar Therapeutics - Common Stock?
The market capitalization of Nektar Therapeutics - Common Stock is 5.79B
How many shares of Nektar Therapeutics - Common Stock are outstanding?
Nektar Therapeutics - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.